Supreme Court Hands Down Bilski Decision

Although it affirmed the ultimate conclusion of non-patentability, today the U.S. Supreme Court has once again rejected the Court of Appeals for the Federal Circuit’s attempt to limit the scope of patent law through use of bright-line tests. The appellate...

Novartis Before India’s Supreme Court: What’s Really At Stake?

As the Novartis Glivec patent case in India reaches the final phase of a long-running legal battle, there’s one point on which both the Swiss pharmaceutical company and its critics agree: the significance of this case goes far beyond the protection of a single...
Maximize the value of your intellectual property. Schedule a free consultation.